Skip to product information
1 of 1

BT Lab

SKU:E0037Ra

Rat B-cell leukemia/lymphoma 2,Bcl-2 ELISA Kit

Rat B-cell leukemia/lymphoma 2,Bcl-2 ELISA Kit

Regular price $428.00 USD
Regular price Sale price $428.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Standard Range
Sensitivity

Contact us for 48 wells and bulk quote

Introducing the Rat B-cell leukemia/lymphoma 2, Bcl-2 ELISA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of B-cell leukemia/lymphoma 2 (Bcl-2) in rat samples. This ELISA kit is meticulously crafted to cater to the needs of researchers and scientists in the field of oncology, enabling them to delve deeper into the intricate mechanisms underlying Bcl-2 expression.

With its advanced technology and high sensitivity, this ELISA kit offers a reliable and precise method for quantifying Bcl-2 levels in rat samples. By utilizing a solid-phase sandwich enzyme-linked immunosorbent assay, this kit ensures optimal specificity and minimal cross-reactivity, thereby ensuring accurate and reproducible results.

The Rat B-cell leukemia/lymphoma 2, Bcl-2 ELISA Kit boasts a user-friendly protocol, allowing for seamless integration into laboratory workflows. Its comprehensive package includes all necessary components, including pre-coated microplates, detection antibodies, standards, and buffers, ensuring convenience and ease of use.

This ELISA kit exhibits exceptional performance characteristics, with a wide dynamic range and low detection limit, enabling the precise quantification of Bcl-2 levels across a broad spectrum. Its robustness and reliability make it an indispensable tool for researchers seeking to unravel the intricate role of Bcl-2 in rat B-cell leukemia/lymphoma.

In summary, the Rat B-cell leukemia/lymphoma 2, Bcl-2 ELISA Kit offers a state-of-the-art solution for the accurate and efficient detection of Bcl-2 in rat samples. With its advanced technology, user-friendly protocol, and exceptional performance characteristics, this kit empowers researchers to gain deeper insights into the complex mechanisms underlying B-cell leukemia/lymphoma, ultimately contributing to advancements in the field of oncology.

View full details